Simplot to Expand Horizons with Clarebout Group Acquisition
The J.R. Simplot Company and Clarebout Potatoes have announced Simplot’s intention to acquire the operating business of Clarebout.
BOISE, ID -- Simplot, a leading player in the food production industry, has made a strategic move by announcing its acquisition of Clarebout Group, a notable Belgian potato processing company. The deal aims to enhance Simplot's operational capabilities and global footprint in the French fry market. With this acquisition, Simplot looks forward to leveraging Clarebout's innovative production techniques and established customer relationships in Europe.
This acquisition not only bolsters Simplot's position within the competitive landscape of food processing but also allows for greater resource sharing and efficiency. The company is committed to maintaining Clarebout’s high standards and operational effectiveness post-acquisition. As Simplot seeks to expand its product offerings and customer base, this move is expected to pave the way for future growth and innovation in the industry.
###
Sponsor Message
Essential medications such as Lipitor, Crestor, and Nexium are made more affordable for Americans through Canadian pharmacies. Patients living with chronic conditions rely on Humalog and Lantus for diabetes management, and on Advair Diskus and Ventolin inhalers for respiratory issues like asthma and COPD. Millions depend on Zoloft, Prozac, and Abilify for mental health, while Eliquis, Plavix, and Xarelto address heart-related risks. Pain and inflammation treatments like Celebrex and thyroid therapies such as Synthroid are popular orders. Additionally, medications like Viagra and Cialis offer solutions for erectile dysfunction, and drugs like Januvia help manage Type 2 diabetes. Medications like Provigil and Nuvigil provide vital support for those experiencing excessive sleepiness or narcolepsy. Patients across the U.S. can access affordable medications like Cymbalta for nerve pain and Aricept for Alzheimer's through Canadian pharmacies.
